Traumatic Brain InjuryHOME-TBINCT07733336
Home-Based Exergame Motor-Cognitive Rehabilitation for Traumatic Brain Injury
A study testing HOME-EXER telerehabilitation protocol and OUT-REHAB rehabilitation protocol in people with Traumatic Brain Injury, run by Fondazione Don Carlo Gnocchi ETS at 2 sites in Italy.
Trial summary
The goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation program in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation. Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Traumatic Brain Injury
- What is being tested?
- HOME-EXER telerehabilitation protocol and OUT-REHAB rehabilitation protocol
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesItaly
- Study dates
- 3 Nov 2026to 31 Mar 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
TBI patients Inclusion Criteria
- Discharge from intensive inpatient post-acute rehabilitation following a first traumatic brain injury (TBI).
- Level of Cognitive Functioning Scale (LCF) score ≥ 6, indicating appropriate and goal-directed cognitive responses.
- Ability to walk at least 30 meters, with or without an assistive device.
- Ability to maintain an unsupported standing position for at least 3 minutes.
- Provision of written informed consent.
TBI patients Exclusion Criteria
- Diagnosis or suspected diagnosis of a neurodegenerative disorder.
- Previous history of traumatic brain injury.
- History of major psychiatric disorders (e.g., schizophrenia or bipolar disorder), primary sleep disorders, or epilepsy.
- Severe visual or auditory impairment that could interfere with study assessments or participation in the rehabilitation program.
- Severe expressive and/or receptive aphasia.
- Language barriers preventing reliable cognitive assessment or informed consent procedures.
- Current pregnancy.
Healthy Subjects - Exclusion Criteria
- Presence of any neurological, sensrory, cognitive, psychiatric, cardiopulmonary, or musculoskeletal condition that may affect study participation or outcome measures
- Language barriers preventing reliable cognitive assessment or informed consent procedures.
- Current pregnancy.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Angela Comanducci contact
Italy2 sites
Istituto Auxologico Italiano IRCCS
Milan, Italy, 20122
Antonio Caronni, +393887770233, antonio.caronni@unimi.it
Antonio Caronni
IRCCS Fondazione Don Carlo Gnocchi ETS
Milan, Italy, 20148
Ilaria Carpinella, +390240308315, icarpinella@dongnocchi.it
Angela Comanducci, acomanducci@dongnocchi.it
About this study
Official title: Effectiveness of Home-Based Exergame Motor-Cognitive Rehabilitation Versus Outpatient Multidisciplinary Rehabilitation in Individuals With Traumatic Brain Injury: A Pilot Controlled Trial
The goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation program in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation.
The main questions it aims to answer are:
Read more
- Does home-based cognitive-motor telerehabilitation improve functional independence, cognitive performance, mobility, and quality of life in individuals with TBI?
- Are the effects of home-based cognitive-motor telerehabilitation superior to those achieved with standard outpatient rehabilitation?
The study will compare a home-based cognitive-motor telerehabilitation program with standard outpatient rehabilitation to determine their relative effects on functional recovery.
Participants will:
- Receive either home-based cognitive-motor telerehabilitation or standard outpatient rehabilitation, according to the assigned treatment pathway. Both rehabilitation programs consist of 20 sessions lasting 45 minutes each, three times per week.
- Undergo clinical, cognitive, and motor assessments at predefined study time points: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
- Be evaluated for changes in functional independence, cognitive functioning, mobility, quality of life, and caregiver burden.
Read the detailed description
Traumatic brain injury (TBI) is one of the leading causes of disability among young adults and is associated with a substantial economic burden on healthcare systems, as well as on patients and their families.
TBI may result in cognitive impairments, including deficits in attention, memory, and executive functions, as well as behavioral disturbances such as apathy, anxiety, and depression. In a smaller proportion of cases, motor dysfunctions, including gait and balance impairments, may also occur. These deficits negatively affect patients' independence and social participation and may also reduce caregivers' quality of life.
Conventional rehabilitation for individuals with TBI typically relies on multidisciplinary interventions, including cognitive training, physiotherapy, and occupational therapy. Although these approaches may improve specific functional domains, evidence supporting their effectiveness in enhancing overall independence and social participation remains limited. Therefore, there is a need to develop more targeted and personalized neurorehabilitation programs based on clinical, instrumental, and biological biomarkers, while ensuring continuity of care through integrated hospital-to-home rehabilitation pathways.
In the post-discharge setting, combined cognitive-motor rehabilitation has gained increasing attention due to the close interaction between motor and cognitive functions in everyday activities. In particular, telerehabilitation delivered through virtual reality-based exergames has shown promising results in improving mobility, cognitive performance, and functional independence in individuals with TBI. Compared with traditional face-to-face rehabilitation, which typically requires one-to-one therapist supervision, telerehabilitation enables patients to perform training at home through synchronous, asynchronous, or hybrid modalities, providing a more flexible and efficient model of care while reducing travel requirements and waiting times for rehabilitation services.
In light of the above, this pilot controlled, non-randomized, single-blind (assessor-blinded) clinical trial aims to investigate the effectiveness of home-based cognitive-motor telerehabilitation as a post-discharge continuity-of-care intervention compared with standard outpatient rehabilitation in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation. We hypothesize that participants receiving the experimental intervention will demonstrate greater or at least comparable improvements in functional independence, cognitive performance, mobility, and quality of life than those receiving conventional outpatient rehabilitation, while also reducing caregiver burden.
- Conditions
- Traumatic Brain Injury
- Being tested
- HOME-EXER telerehabilitation protocol, OUT-REHAB rehabilitation protocol
- Keywords
- Traumatic Brain Injury;, Telerehabilitation, motor function, cognitive function, multidisciplinary rehabilitation
- Medical subject headings
- Brain Injuries, Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HOME-EXER telerehabilitation protocolOther
Participants will follow the HOME-EXER telerehabilitation protocol
OUT-REHAB rehabilitation protocolOther
Participants will follow the OUT-REHAB rehabilitation protocol
| Study group | Role | What they receive |
|---|---|---|
| HOME-EXER: Motor-cognitive home-based telerehabilitation | Experimental | Participants will receive a home-based motor-cognitive telerehabilitation program delivered through the Homing system (Tecnobody, Italy). The intervention consists of combined motor and cognitive exergames with real-time visual and auditory feedback, aimed at improving cognitive-motor integration during activities that simulate daily living tasks. The program includes 20 sessions (45 minutes per session) over 7 weeks (three sessions per week), consisting of one remotely supervised synchronous session and two self-administered asynchronous sessions per week. Training difficulty and exercise content may be remotely adjusted by the clinical team according to the participant's performance and rehabilitation needs. Receives: Other: HOME-EXER telerehabilitation protocol |
| OUT-REHAB: Multidisciplinary Outpatient Rehabilitation | Active comparator | Participants will receive conventional multidisciplinary outpatient rehabilitation (usual care) following discharge from intensive inpatient neurorehabilitation. The program consists of individualized motor rehabilitation, cognitive rehabilitation, and occupational therapy delivered by qualified healthcare professionals. Treatment includes 20 sessions (45 minutes/session) over 7 weeks (three sessions per week), with rehabilitation activities tailored to each participant's clinical needs according to standard clinical practice. Receives: Other: OUT-REHAB rehabilitation protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Disability Rating Scale (DRS)
The Disability Rating Scale (DRS) is a validated measure of global functional disability after traumatic brain injury. It assesses impairment, disability, and participation restrictions across domains of consciousness, self-care, dependence, and psychosocial functioning. Scores range from 0 to 29, with higher scores indicating greater disability.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0)
Secondary outcomes (13)
Montreal Cognitive Assessment (MoCA)
A validated screening tool used to assess global cognitive functioning. Total scores range from 0 to 30, with higher scores indicating better cognitive performance.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Symbol Digit Modalities Test (SDMT)
A validated neuropsychological test used to assess information processing speed, attention, and visual scanning. Participants are required to match symbols with corresponding numbers according to a reference key within 90 seconds. The score consists of the number of correct symbol-digit pairings completed in 90 seconds, with higher scores indicating better cognitive performance and faster processing speed.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
California Verbal Learning Test II (CVLT-II)
A validated neuropsychological test used to assess verbal learning and memory. A list of words is read aloud over five consecutive trials, and after each presentation participants are asked to freely recall as many words as possible. The score consists of the total number of correctly recalled words across the five learning trials, with higher scores indicating better verbal learning and memory performance.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Brief Visuospatial Memory Test - Revised (BVMT-R)
A validated neuropsychological test used to assess visuospatial learning and memory. Participants are shown a display containing six geometric figures for 10 seconds and are then asked to reproduce them from memory. This procedure is repeated over three learning trials. The score consists of the total number of points obtained across the three recall trials, based on the accuracy and location of the reproduced figures, with higher scores indicating better visuospatial learning and memory performance.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Hospital Anxiety and Depression Scale (HADS)
A validated self-report questionnaire used to assess symptoms of anxiety and depression in medical and rehabilitation settings. The scale consists of 14 items, divided into two subscales: HADS-Anxiety (HADS-A) and HADS-Depression (HADS-D), each comprising 7 items. Scores for each subscale range from 0 to 21, with higher scores indicating greater levels of anxiety or depressive symptoms. The total HADS score ranges from 0 to 42.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Berg Balance Scale (BBS)
A validated clinical scale used to assess functional balance. The assessment consists of 14 functional tasks involving sitting, standing, transfers, reaching, turning, and single-leg stance. Each item is scored from 0 to 4, with a total score ranging from 0 to 56. Higher scores indicate better balance performance. Kinematic data will be recorded by an inertial sensor on lower back.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Six-Minute Walk Test (6MWT)
A validated test used to assess walking capacity and endurance. Participants are instructed to walk as far as possible along a 30-meter corridor for 6 minutes, with rest periods and walking aids allowed if necessary. The outcome measure is the total distance walked in 6 minutes, with greater distances indicating better walking capacity and endurance. Kinematic data will be recorded by three inertial sensors on lower back and feet.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Timed Up and Go (TUG) Test
A validated measure of functional mobility and dynamic balance that assesses the time required for a participant to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. The test is administered under both single-task and cognitive dual-task conditions. In the dual-task condition (TUG-DT), participants perform the TUG while simultaneously completing a cognitive task consisting of generating alternating letters of the alphabet during walking. Outcome measures include completion time (seconds), and the Dual-Task Cost (DTC) for motor and cognitive performance, calculated as the percentage change between single-task and dual-task conditions. Lower completion times and lower DTC values indicate better functional mobility and dual-task ability. Kinematic data will be recorded by an inertial sensor on lower back.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
EuroQol 5-Dimensions 5-Levels Health Questionnaire (EQ-5D-5L)
A validated self-report measure of health-related quality of life, used for clinical and economic appraisal.
The questionnaire assesses five dimensions of health status: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity ranging from no problems to extreme problems. Responses are converted into a health utility index score, with higher scores indicating better perceived health status. The instrument also includes a Visual Analogue Scale (EQ VAS) ranging from 0 (worst imaginable health) to 100 (best imaginable health), on which participants rate their overall health.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Quality Of Life After Brain Injury (QOLIBRI)
A validated, disease-specific self-report questionnaire designed to assess health-related quality of life in individuals with traumatic brain injury (TBI). The instrument evaluates six domains: cognition, self, daily life and autonomy, social relationships, emotions, and physical problems. Items are rated on a 5-point scale, and responses are combined to generate a total score ranging from 0 to 100, with higher scores indicating better perceived quality of life after brain injury.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Community Integration Questionnaire (CIQ)
A validated questionnaire used to assess community integration following acquired brain injury. The instrument evaluates participation in three domains: home integration, social integration, and productive activities (e.g., work, education, or volunteering). Scores from individual items are summed to generate a total score, typically ranging from 0 to 29, with higher scores indicating greater independence and community participation.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Caregiver Burden Inventory (CBI)
Caregiver Burden Inventory (CBI): A validated self-report questionnaire used to assess the multidimensional burden experienced by caregivers. The instrument consists of 24 items grouped into five domains: time-dependence burden, developmental burden, physical burden, social burden, and emotional burden. Each item is rated on a 5-point scale (0-4), yielding a total score ranging from 0 to 96, with higher scores indicating greater caregiver burden. The CBI is widely used to evaluate the impact of caregiving responsibilities on caregivers' well-being and daily functioning.
Measured: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Adverse events
Organized reporting of adverse events occurring during the study
Measured: From T0 (hospital discharge, pre-intervention) to T2 (follow-up, 6 months after T0).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2026
- Study start3 Nov 2026 (estimated)
- Primary completion31 Mar 2029 (estimated)
- Study completion31 Mar 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for Traumatic Brain InjuryStudies of the same condition, open and under way.
- More trials run by Fondazione Don Carlo Gnocchi ETSThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Pilot controlled, non-randomized, single-blind (assessor-blinded) clinical trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETS
- Sponsor type
- University, hospital or other
- Collaborators
- Istituto Auxologico Italiano
- Responsible party
- Principal investigator, Ilaria Carpinella, Fondazione Don Carlo Gnocchi ETS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07733336
- Sponsor's protocol ID
- TRUSTME-B
- Other IDs
- RF-2024-12379258, RF-2024-12379258
- Acronym
- HOME-TBI
- Status last verified
- Jul 2026
- First submitted
- 22 Jul 2026
- Last updated
- 11 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data will be available upon request
Publications
Walker WC, Pickett TC. Motor impairment after severe traumatic brain injury: A longitudinal multicenter study. J Rehabil Res Dev. 2007;44(7):975-82. doi: 10.1682/jrrd.2006.12.0158.
PubMed 18075954Riggio S. Traumatic brain injury and its neurobehavioral sequelae. Neurol Clin. 2011 Feb;29(1):35-47, vii. doi: 10.1016/j.ncl.2010.10.008.
PubMed 21172569Manivannan S, Al-Amri M, Postans M, Westacott LJ, Gray W, Zaben M. The Effectiveness of Virtual Reality Interventions for Improvement of Neurocognitive Performance After Traumatic Brain Injury: A Systematic Review. J Head Trauma Rehabil. 2019 Mar/Apr;34(2):E52-E65. doi: 10.1097/HTR.0000000000000412.
PubMed 30045223Kumar KS, Samuelkamaleshkumar S, Viswanathan A, Macaden AS. Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes. Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD007935. doi: 10.1002/14651858.CD007935.pub2.
PubMed 28631816Howe EI, Andelic N, Fure SCR, Roe C, Soberg HL, Hellstrom T, Spjelkavik O, Enehaug H, Lu J, Ugelstad H, Lovstad M, Aas E. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial. BMC Health Serv Res. 2022 Feb 12;22(1):185. doi: 10.1186/s12913-022-07585-3.
PubMed 35151285Herold F, Hamacher D, Schega L, Muller NG. Thinking While Moving or Moving While Thinking - Concepts of Motor-Cognitive Training for Cognitive Performance Enhancement. Front Aging Neurosci. 2018 Aug 6;10:228. doi: 10.3389/fnagi.2018.00228. eCollection 2018.
PubMed 30127732D'Ippolito M, Aloisi M, Azicnuda E, Silvestro D, Giustini M, Verni F, Formisano R, Bivona U. Changes in Caregivers Lifestyle after Severe Acquired Brain Injury: A Preliminary Investigation. Biomed Res Int. 2018 Jul 3;2018:2824081. doi: 10.1155/2018/2824081. eCollection 2018.
PubMed 30065934Calabro RS, Bonanno M, Torregrossa W, Cacciante L, Celesti A, Rifici C, Tonin P, De Luca R, Quartarone A. Benefits of Telerehabilitation for Patients With Severe Acquired Brain Injury: Promising Results From a Multicenter Randomized Controlled Trial Using Nonimmersive Virtual Reality. J Med Internet Res. 2023 Aug 21;25:e45458. doi: 10.2196/45458.
PubMed 37490017Brazinova A, Rehorcikova V, Taylor MS, Buckova V, Majdan M, Psota M, Peeters W, Feigin V, Theadom A, Holkovic L, Synnot A. Epidemiology of Traumatic Brain Injury in Europe: A Living Systematic Review. J Neurotrauma. 2021 May 15;38(10):1411-1440. doi: 10.1089/neu.2015.4126. Epub 2018 Dec 19.
PubMed 26537996Avramovic P, Rietdijk R, Attard M, Kenny B, Power E, Togher L. Cognitive and Behavioral Digital Health Interventions for People with Traumatic Brain Injury and Their Caregivers: A Systematic Review. J Neurotrauma. 2023 Feb;40(3-4):159-194. doi: 10.1089/neu.2021.0473. Epub 2022 Aug 29.
PubMed 35819294Alashram AR, Padua E, Annino G. Virtual reality for balance and mobility rehabilitation following traumatic brain injury: A systematic review of randomized controlled trials. J Clin Neurosci. 2022 Nov;105:115-121. doi: 10.1016/j.jocn.2022.09.012. Epub 2022 Sep 28.
PubMed 36182811
Study at a glance
From the registry record, last updated by the sponsor on 11 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Home-Based Exergame Motor-Cognitive Rehabilitation Versus Outpatient Multidisciplinary Rehabilitation in Individuals With Traumatic Brain Injury: A Pilot Controlled Trial
- ClinicalTrials.gov ID
- NCT07733336
- Acronym / sponsor ID
- HOME-TBI / TRUSTME-B
- Conditions
- Traumatic Brain Injury
- Keywords
- Traumatic Brain Injury;, Telerehabilitation, motor function, cognitive function, multidisciplinary rehabilitation
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETSUniversity, hospital or other
- Collaborators
- Istituto Auxologico Italiano
- Study start
- 3 Nov 2026 (estimated)
- Primary completion
- 31 Mar 2029 (estimated)
- Study completion
- 31 Mar 2029 (estimated)
- First posted
- 29 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation program in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation.
The main questions it aims to answer are:
- Does home-based cognitive-motor telerehabilitation improve functional independence, cognitive performance, mobility, and quality of life in individuals with TBI?
- Are the effects of home-based cognitive-motor telerehabilitation superior to those achieved with standard outpatient rehabilitation?
The study will compare a home-based cognitive-motor telerehabilitation program with standard outpatient rehabilitation to determine their relative effects on functional recovery.
Participants will:
- Receive either home-based cognitive-motor telerehabilitation or standard outpatient rehabilitation, according to the assigned treatment pathway. Both rehabilitation programs consist of 20 sessions lasting 45 minutes each, three times per week.
- Undergo clinical, cognitive, and motor assessments at predefined study time points: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
- Be evaluated for changes in functional independence, cognitive functioning, mobility, quality of life, and caregiver burden.
Detailed description
Traumatic brain injury (TBI) is one of the leading causes of disability among young adults and is associated with a substantial economic burden on healthcare systems, as well as on patients and their families.
TBI may result in cognitive impairments, including deficits in attention, memory, and executive functions, as well as behavioral disturbances such as apathy, anxiety, and depression. In a smaller proportion of cases, motor dysfunctions, including gait and balance impairments, may also occur. These deficits negatively affect patients' independence and social participation and may also reduce caregivers' quality of life.
Conventional rehabilitation for individuals with TBI typically relies on multidisciplinary interventions, including cognitive training, physiotherapy, and occupational therapy. Although these approaches may improve specific functional domains, evidence supporting their effectiveness in enhancing overall independence and social participation remains limited. Therefore, there is a need to develop more targeted and personalized neurorehabilitation programs based on clinical, instrumental, and biological biomarkers, while ensuring continuity of care through integrated hospital-to-home rehabilitation pathways.
In the post-discharge setting, combined cognitive-motor rehabilitation has gained increasing attention due to the close interaction between motor and cognitive functions in everyday activities. In particular, telerehabilitation delivered through virtual reality-based exergames has shown promising results in improving mobility, cognitive performance, and functional independence in individuals with TBI. Compared with traditional face-to-face rehabilitation, which typically requires one-to-one therapist supervision, telerehabilitation enables patients to perform training at home through synchronous, asynchronous, or hybrid modalities, providing a more flexible and efficient model of care while reducing travel requirements and waiting times for rehabilitation services.
In light of the above, this pilot controlled, non-randomized, single-blind (assessor-blinded) clinical trial aims to investigate the effectiveness of home-based cognitive-motor telerehabilitation as a post-discharge continuity-of-care intervention compared with standard outpatient rehabilitation in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation. We hypothesize that participants receiving the experimental intervention will demonstrate greater or at least comparable improvements in functional independence, cognitive performance, mobility, and quality of life than those receiving conventional outpatient rehabilitation, while also reducing caregiver burden.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Pilot controlled, non-randomized, single-blind (assessor-blinded) clinical trial
| Arm | Type | Receives |
|---|---|---|
| HOME-EXER: Motor-cognitive home-based telerehabilitation | Experimental | Other: HOME-EXER telerehabilitation protocolParticipants will receive a home-based motor-cognitive telerehabilitation program delivered through the Homing system (Tecnobody, Italy). The intervention consists of combined motor and cognitive exergames with real-time visual and auditory feedback, aimed at improving cognitive-motor integration during activities that simulate daily living tasks. The program includes 20 sessions (45 minutes per session) over 7 weeks (three sessions per week), consisting of one remotely supervised synchronous session and two self-administered asynchronous sessions per week. Training difficulty and exercise content may be remotely adjusted by the clinical team according to the participant's performance and rehabilitation needs. |
| OUT-REHAB: Multidisciplinary Outpatient Rehabilitation | Active comparator | Other: OUT-REHAB rehabilitation protocolParticipants will receive conventional multidisciplinary outpatient rehabilitation (usual care) following discharge from intensive inpatient neurorehabilitation. The program consists of individualized motor rehabilitation, cognitive rehabilitation, and occupational therapy delivered by qualified healthcare professionals. Treatment includes 20 sessions (45 minutes/session) over 7 weeks (three sessions per week), with rehabilitation activities tailored to each participant's clinical needs according to standard clinical practice. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HOME-EXER telerehabilitation protocolParticipants will follow the HOME-EXER telerehabilitation protocol | Other | HOME-EXER: Motor-cognitive home-based telerehabilitation |
| OUT-REHAB rehabilitation protocolParticipants will follow the OUT-REHAB rehabilitation protocol | Other | OUT-REHAB: Multidisciplinary Outpatient Rehabilitation |
Primary outcome
Disability Rating Scale (DRS)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0)
The Disability Rating Scale (DRS) is a validated measure of global functional disability after traumatic brain injury. It assesses impairment, disability, and participation restrictions across domains of consciousness, self-care, dependence, and psychosocial functioning. Scores range from 0 to 29, with higher scores indicating greater disability.
13 secondary outcomes
Montreal Cognitive Assessment (MoCA)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Symbol Digit Modalities Test (SDMT)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
California Verbal Learning Test II (CVLT-II)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Brief Visuospatial Memory Test - Revised (BVMT-R)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Hospital Anxiety and Depression Scale (HADS)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Berg Balance Scale (BBS)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Six-Minute Walk Test (6MWT)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Timed Up and Go (TUG) Test
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
EuroQol 5-Dimensions 5-Levels Health Questionnaire (EQ-5D-5L)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Quality Of Life After Brain Injury (QOLIBRI)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Community Integration Questionnaire (CIQ)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Caregiver Burden Inventory (CBI)
Time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
Adverse events
Time frame: From T0 (hospital discharge, pre-intervention) to T2 (follow-up, 6 months after T0).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Aug 2026.
- Background: PubMed 18075954Walker WC, Pickett TC. Motor impairment after severe traumatic brain injury: A longitudinal multicenter study. J Rehabil Res Dev. 2007;44(7):975-82. doi: 10.1682/jrrd.2006.12.0158.
- Background: PubMed 21172569Riggio S. Traumatic brain injury and its neurobehavioral sequelae. Neurol Clin. 2011 Feb;29(1):35-47, vii. doi: 10.1016/j.ncl.2010.10.008.
- Background: PubMed 30045223Manivannan S, Al-Amri M, Postans M, Westacott LJ, Gray W, Zaben M. The Effectiveness of Virtual Reality Interventions for Improvement of Neurocognitive Performance After Traumatic Brain Injury: A Systematic Review. J Head Trauma Rehabil. 2019 Mar/Apr;34(2):E52-E65. doi: 10.1097/HTR.0000000000000412.
- Background: PubMed 28631816Kumar KS, Samuelkamaleshkumar S, Viswanathan A, Macaden AS. Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes. Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD007935. doi: 10.1002/14651858.CD007935.pub2.
- Background: PubMed 35151285Howe EI, Andelic N, Fure SCR, Roe C, Soberg HL, Hellstrom T, Spjelkavik O, Enehaug H, Lu J, Ugelstad H, Lovstad M, Aas E. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial. BMC Health Serv Res. 2022 Feb 12;22(1):185. doi: 10.1186/s12913-022-07585-3.
- Background: PubMed 30127732Herold F, Hamacher D, Schega L, Muller NG. Thinking While Moving or Moving While Thinking - Concepts of Motor-Cognitive Training for Cognitive Performance Enhancement. Front Aging Neurosci. 2018 Aug 6;10:228. doi: 10.3389/fnagi.2018.00228. eCollection 2018.
- Background: PubMed 30065934D'Ippolito M, Aloisi M, Azicnuda E, Silvestro D, Giustini M, Verni F, Formisano R, Bivona U. Changes in Caregivers Lifestyle after Severe Acquired Brain Injury: A Preliminary Investigation. Biomed Res Int. 2018 Jul 3;2018:2824081. doi: 10.1155/2018/2824081. eCollection 2018.
- Background: PubMed 37490017Calabro RS, Bonanno M, Torregrossa W, Cacciante L, Celesti A, Rifici C, Tonin P, De Luca R, Quartarone A. Benefits of Telerehabilitation for Patients With Severe Acquired Brain Injury: Promising Results From a Multicenter Randomized Controlled Trial Using Nonimmersive Virtual Reality. J Med Internet Res. 2023 Aug 21;25:e45458. doi: 10.2196/45458.
- Background: PubMed 26537996Brazinova A, Rehorcikova V, Taylor MS, Buckova V, Majdan M, Psota M, Peeters W, Feigin V, Theadom A, Holkovic L, Synnot A. Epidemiology of Traumatic Brain Injury in Europe: A Living Systematic Review. J Neurotrauma. 2021 May 15;38(10):1411-1440. doi: 10.1089/neu.2015.4126. Epub 2018 Dec 19.
- Background: PubMed 35819294Avramovic P, Rietdijk R, Attard M, Kenny B, Power E, Togher L. Cognitive and Behavioral Digital Health Interventions for People with Traumatic Brain Injury and Their Caregivers: A Systematic Review. J Neurotrauma. 2023 Feb;40(3-4):159-194. doi: 10.1089/neu.2021.0473. Epub 2022 Aug 29.
- Background: PubMed 36182811Alashram AR, Padua E, Annino G. Virtual reality for balance and mobility rehabilitation following traumatic brain injury: A systematic review of randomized controlled trials. J Clin Neurosci. 2022 Nov;105:115-121. doi: 10.1016/j.jocn.2022.09.012. Epub 2022 Sep 28.
- Individual participant dataSharing planned: Yes. Data will be available upon request
Related trials for Traumatic Brain Injury
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
Not yet recruitingPhase 1
Nanopulse Laser Therapy
TBI (Traumatic Brain Injury)
RecruitingObservational study
Effect of Different Intravenous Fluids on Post-operative Chronic Subdural Hematoma Size and Recurrence
Chronic Subdural Hematoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Angela Comanducci contact
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HOME-EXER telerehabilitation protocol and OUT-REHAB rehabilitation protocol in people with Traumatic Brain Injury, run by Fondazione Don Carlo Gnocchi ETS at 2 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ilaria Carpinella (+390240308315, icarpinella@dongnocchi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Disability Rating Scale (DRS) (time frame: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07733336, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.